贝莱德看淡欧洲股票 新兴市场股票评级上调至增持
全球最大资产管理公司贝莱德(BlackRock)将欧洲股票评级下调至中性,因当地疫情再次爆发并实施新的限制措施。另外,美国民主党可能在选举中大胜,故将新兴市场股票评级提高至增持。
贝莱德解释,由於民主党大胜可能性提升,美国新一届政府的财政开支将增加,外交政策会更加稳定,再加上美元走软以及实际利率跌至负水平,这将有利於发展中市场的资产表现。
贝莱德还将亚洲固定收益评级上调至增持,认为中国及其他亚洲国家在遏制疫情方面做得更好,经济复苏方面进一步领先其他国家。不过,贝莱德将日本股票评级降至减持,因日圆走强可能会对出口商构成压力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.